(Q43702211)

26 November 2017

title

Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin (English)

1 reference

26 November 2017

1 reference

1 reference

J W Miller

1

1 reference

26 November 2017

A Skerjanec

2

1 reference

26 November 2017

M P Knadler

3

1 reference

26 November 2017

A Ghosh

4

1 reference

26 November 2017

S R Allerheiligen

5

1 reference

26 November 2017

publication date

1 July 2001

1 reference

26 November 2017

published in

Pharmaceutical Research

1 reference

26 November 2017

volume

18

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

1024-1028

1 reference

Characterization of the "estrogenicity" of tamoxifen and raloxifene in HepG2 cells: regulation of gene expression from an ERE controlled reporter vector versus regulation of the endogenous SHBG and PS2 genes

26 November 2017

cites work

1 reference

12 December 2020

Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect

1 reference

12 December 2020

Kinetics of warfarin absorption in man

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

The effects of therapy with oestriol succinate and ethinyl oestradiol on the haemostatic mechanism in post-menopausal women

1 reference

12 December 2020

A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens*

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Further studies on plasma proteins, lipids, and dye- and drug-binding in a child with analbuminemia

1 reference

12 December 2020

Effect of oral contraceptives on vitamin K-dependent clotting activity.

1 reference

12 December 2020

Coagulation system changes in post-menopausal women receiving oestrogen preparations

1 reference

12 December 2020

Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity

1 reference

12 December 2020

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1010904815275

1 reference

26 November 2017

1 reference